独立董事关于第五届董事会第十七次会议相关事项的独立意见 2. 对外担保情况 北京万邦达环保技术股份有限公司 独立董事关于第五届董事会第十七次会议相关事项的 独立意见 根据《中华人民共和国证券法》、《深圳证券交易所创业板股票上市规则》、 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》、 《北京万邦达环保技术股份有限公司章程》、北京万邦达环保技术股份有限公司 （以下简称"公司"）《独立董事工作制度》等相关法律、法规、规章制度的有关 规定，作为公司的独立董事，对公司关于第五届董事会第十七次会议相关事项发 表如下独立意见： 一、关于公司控股股东及其他关联方资金占用和对外担保情况的独立意见 根据中国证券监督管理委员会《关于规范上市公司与关联方资金往来及上市 公司对外担保若干问题的通知》、《关于规范上市公司对外担保的通知》、《关于在 上市公司建立独立董事制度的指导意见》及《公司章程》的有关规定，作为公司 独立董事，本着实事求是的工作态度，对公司报告期内控股股东及其他关联方占 用资金和公司对外担保的情况进行了认真的调查和核查，发表独立意见如下： 1. 控股股东及其关联方占用资金情况 截止本报告期 ...

第五届监事会第十四次会议决议公告 证券代码：300055 证券简称：万邦达 公告编号：2023-045 本议案具体内容详见中国证监会指定信息披露媒体同日相关公告。 表决结果：3 票同意、0 票反对、0 票弃权。 二、审议通过《关于<2023 年半年度募集资金存放与使用情况的专项报告>的 议案》 本议案具体内容详见中国证监会指定信息披露媒体同日相关公告。 表决结果：3 票同意、0 票反对、0 票弃权。 北京万邦达环保技术股份有限公司 第五届监事会第十四次会议决议公告 本公司及监事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 北京万邦达环保技术股份有限公司（以下简称"公司"）于 2023 年 8 月 14 日 以电子邮件的方式向全体监事发出召开第五届监事会第十四次会议的通知。会议 于 2023 年 8 月 23 日下午 15:00 在公司会议室以现场会议的方式召开，以投票方 式表决。本次会议应出席监事 3 人，实际出席监事 3 人。会议由监事会主席吕晖 先生召集并主持。会议的召集和召开符合《中华人民共和国公司法》和《北京万 邦达环保技术股份有限公司章程》的有关规定。 经全体监事审 ...

证券代码：300055 证券简称：万邦达 公告编号：2023-049 关于监事辞职及补选监事的公告 北京万邦达环保技术股份有限公司 关于监事辞职及补选监事的公告 本公司及监事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事辞职情况 北京万邦达环保技术股份有限公司（以下简称"公司"）于近日收到监事张卉 女士的书面辞职报告。张卉女士由于个人原因申请辞去第五届监事会监事职务， 辞职后张卉女士继续在公司任职。张卉女士原定任期至 2025 年 4 月 14 日第五届 监事会届满之日止。 截至本公告披露日，张卉女士持有公司 98,600 股股份。根据《深圳证券交易 所上市公司股东及董事、监事、高级管理人员减持股份实施细则》等相关规定， 张卉女士辞职后，其所持公司股份将严格按照相关法律、法规及相关承诺进行管 理。 由于张卉女士的辞职将导致公司监事会成员人数低于法定人数，根据《中华 人民共和国公司法》、《深圳证券交易所创业板上市公司规范运作指引》以及《公 司章程》的规定，其辞职报告将在公司股东大会选举出新的监事后方可生效。在 此之前，张卉女士仍将按照相关法律、法规的规定，履行监事职责。 ...

2023 年 5 月 8 日投资者关系活动记录表 证券代码：300055 证券简称：万邦达 北京万邦达环保技术股份有限公司 投资者关系活动记录表 | --- | |----------------| | 投资者关系活动 | | 类别 | | | | | | | | 参与单位名称及 | | 人员姓名 | | 时间 | | 地点 | | 上市公司接待 | | 人员姓名 | | | | | | | 公司于 2023 年 5 月 8 日（星期一）下午 15：00－17：00 在 "价值在线"（www.ir-online.cn）举办 2022 年度网上业绩说明会。 本次业绩说明会采用网络远程方式举行，公司对投资者关注的问 题进行了回复，问答情况如下： 投资者关系活动 主要内容介绍 问：公司今年归属净利润较往年有一定程度的下降，想问一 下各位领导关于此问题公司是否后续有相关战略调整？ 答：尊敬的投资者您好！公司 2022 年归母净利润有所下降主 要系 2021 年度重大资产重组增加了公司非经常性收益以及惠州 伊斯科的毛利率下降幅度较大所致，公司将立足企业发展新阶段， 1 2023 年 5 月 8 日投资者关系活动记录表 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥754,915,822.24, representing a 15.95% increase compared to ¥651,076,008.76 in the same period last year[4] - The net profit attributable to shareholders decreased by 9.27% to ¥23,486,516.56 from ¥25,885,276.72 year-on-year[4] - The net profit after deducting non-recurring gains and losses fell by 29.36% to ¥17,811,547.00 compared to ¥25,214,480.22 in the previous year[4] - Net profit for Q1 2023 was ¥30,359,315.02, a decrease of 25.5% from ¥40,836,625.24 in Q1 2022[27] - The total comprehensive income attributable to the parent company was CNY 23,824,425.57, a decrease of 7.7% compared to CNY 25,822,559.73 in the previous period[28] - Basic and diluted earnings per share were both CNY 0.0281, down from CNY 0.0322 in the previous period[28] Cash Flow - The net cash flow from operating activities significantly declined by 93.01% to ¥8,823,342.38 from ¥126,209,529.99 in the same period last year[4] - Cash inflow from operating activities totaled CNY 903,311,814.21, an increase of 38.2% compared to CNY 653,609,608.97 in the previous period[30] - Cash outflow from operating activities was CNY 894,488,471.83, an increase of 69.5% from CNY 527,400,078.98 in the previous period[30] - The net cash flow from investing activities was -CNY 75,682,866.44, an improvement from -CNY 122,491,501.07 in the previous period[30] - Cash inflow from financing activities was CNY 353,990,383.02, with a net cash flow of CNY 169,991,494.12 compared to -CNY 39,744,666.67 in the previous period[30] - The ending balance of cash and cash equivalents was CNY 588,620,712.80, a decrease of 17.3% from CNY 711,540,120.06 in the previous period[31] Assets and Liabilities - Total assets increased by 2.70% to ¥7,798,473,258.42 from ¥7,593,314,432.81 at the end of the previous year[4] - Total liabilities decreased to ¥2,146,044,768.03 in Q1 2023 from ¥2,316,537,413.99 in Q1 2022, a reduction of 7.3%[23] - The company's total assets increased to ¥7,798,473,258.42 in Q1 2023, compared to ¥7,593,314,432.81 in Q1 2022, reflecting a growth of 2.7%[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 36.142 million[13] - The largest shareholder, Wang Piaoyang, holds 32.46% of shares, amounting to 271,594,216 shares, with 119,370,000 shares pledged[13] - The company has a total of 212,461,923 restricted shares at the end of the reporting period, with 33,653,846 shares expected to be released from restrictions on February 16, 2026[16] Investment and Expenses - The company reported a significant increase in investment income, which rose by 178.54% to ¥9,928,353.94 compared to ¥3,564,363.67 in the previous year[10] - Research and development expenses for Q1 2023 were ¥20,766,090.85, an increase of 9.4% compared to ¥18,991,481.78 in Q1 2022[26] - Total operating costs for Q1 2023 were ¥735,345,049.92, up 20.2% from ¥612,028,896.27 in the same period last year[26] Cash and Equivalents - Cash and cash equivalents increased by 47.66% to ¥853,201,950.23, primarily due to funds received from a specific stock issuance[9] - The company's cash and cash equivalents at the end of the reporting period amount to ¥853,201,950.23, an increase from ¥577,829,903.03 at the beginning of the year[21] - The total current assets increased to ¥2,569,307,075.23 from ¥2,345,492,002.64 at the beginning of the year, reflecting a growth of approximately 9.5%[21]

Financial Performance - Revenue for 2022 reached 2,717.68 million yuan, a 35.25% increase year-over-year, driven by higher production and prices of petrochemical products and the inclusion of Huizhou ECISCO in the consolidation scope[4] - Net profit attributable to shareholders was 78.45 million yuan, a 63.00% decrease year-over-year, primarily due to non-recurring gains from a major asset restructuring in 2021 and a significant decline in Huizhou ECISCO's gross margin[4] - Operating cash flow surged by 192.35% to 877.88 million yuan, reflecting improved cash management and operational efficiency[17] - Basic earnings per share (EPS) decreased by 61.81% to 0.0977 yuan, impacted by the decline in net profit[17] - Total assets grew by 4.70% to 7,593.31 million yuan, while shareholders' equity decreased by 2.42% to 4,980.96 million yuan[17] - Q4 revenue was the highest at 817.95 million yuan, but the company reported a net loss of 23.88 million yuan in the same quarter[20] - The company's gross margin declined significantly due to lower profitability in the Huizhou ECISCO segment[4] - The company reported non-recurring gains and losses totaling RMB 14,031,265.92 in 2022, a significant decrease from RMB 103,445,049.82 in 2021[24] - Government subsidies recognized in 2022 amounted to RMB 4,747,881.84, slightly lower than RMB 4,903,688.72 in 2021[24] - The company achieved a revenue of 2.718 billion yuan in 2022, a year-on-year increase of 35.25%, with the petrochemical new materials business contributing 2.33 billion yuan, accounting for 85.73% of the total revenue[52] - Net profit for 2022 was 106 million yuan, a year-on-year decrease of 61.42%, while net profit attributable to shareholders was 78 million yuan, down 63.00% year-on-year[52] - Operating cash flow increased significantly by 192.35% to 878 million yuan in 2022[52] - The petrochemical products segment saw a revenue increase of 50.76% to 2.33 billion yuan, but its gross margin decreased by 7.94 percentage points to 7.96%[56] - Industrial water treatment revenue decreased by 29.52% to 177.79 million yuan, with a gross margin decline of 2.98 percentage points to 14.78%[56] - The company's hazardous waste treatment segment achieved revenue of 182.35 million yuan, with a gross margin of 29.98%, despite a slight decline of 3.64 percentage points year-on-year[56] - The company's financial investment segment generated revenue of 27.67 million yuan, a year-on-year decrease of 12.37%, but maintained a 100% gross margin[56] - Engineering contracting projects decreased by 86.09% year-on-year, mainly due to no new projects added this year and existing projects nearing completion[61] - Commodity sales (non-petrochemical products) decreased by 74.45% year-on-year, primarily due to reduced sales projects this year[61] - Petrochemical products increased by 64.99% year-on-year, driven by rising raw material procurement prices at Huizhou Yisike and its inclusion in the consolidated financial statements since February last year[62] - The company's contract liabilities decreased by 0.55% to RMB 270,843,323.24 in 2022[76] - The company's long-term debt decreased by 1.17% to RMB 235,500,000.00 in 2022[76] - Cash and cash equivalents decreased by 5.45% to 577.83 million USD, accounting for 7.61% of total assets, primarily due to the purchase of financial products, large certificates of deposit, and payments for the acquisition of minority equity in Huizhou Yisike[80] - Long-term equity investments increased by 6.65% to 554.95 million USD, mainly due to the recognition of investments in Jintai Potash[80] - Construction in progress increased by 4.06% to 679.63 million USD, primarily due to increased investment in the Jilin acrylonitrile project[80] - Total investment for the reporting period was 409.5 million USD, a decrease of 58.49% compared to the previous year[81] - The company's total compensation for key management personnel in 2022 was 244.32 million yuan[110] - The company's total actual payment for directors, supervisors, and senior management in 2022 was 5.6138 million yuan, including 300,000 yuan for independent directors' allowances[130] - The company's cumulative investment and financing amount in various projects has reached tens of billions of yuan, including projects like the BOT project for coal tar lightening wastewater treatment and the non-public offering of shares for refinancing in 2021[113] - The company's financial tools are assessed for expected credit losses based on both individual and portfolio evaluations, considering past events, current conditions, and future economic forecasts[127] - The company categorizes financial instruments into different portfolios based on shared credit risk characteristics, including financial instrument type, credit risk rating, and aging portfolio[127] - The company's internal control audit and financial advisory services were not applicable during the reporting period[163] - The company's entrusted operation income in 2022 was 153.7393 million yuan, an increase of 0.81% year-on-year, with a decrease in overall operating gross margin by 9.11%[167] - The company's rental expenses for various office spaces and facilities totaled 150.85 million yuan annually, with all leases currently in normal operation[169] - The total approved external guarantee quota during the reporting period was 40,000[172] - The actual external guarantee amount during the reporting period was 0[172] - The total approved guarantee quota for subsidiaries during the reporting period was 80,000[173] - The actual guarantee amount for subsidiaries during the reporting period was 50,242.09[173] - The total approved guarantee quota for subsidiaries at the end of the reporting period was 155,000[173] - The actual guarantee balance for subsidiaries at the end of the reporting period was 86,002.89[173] - The total approved guarantee quota at the end of the reporting period was 195,000[173] - The actual guarantee balance at the end of the reporting period was 86,002.89, accounting for 17.27% of the company's net assets[173] - The total amount of entrusted wealth management during the reporting period was 162,508[175] - The outstanding balance of entrusted wealth management at the end of the reporting period was 27,612.09[175] - The company completed the cancellation of 62,089,055 repurchased shares on May 13, 2022[178] - The company extended the entrusted loan principal of Guoyuan Investment for 2 years with an unchanged annual interest rate of 10%, with a remaining principal of RMB 289.7 million as of May 27, 2022[178] - The 2021 annual profit distribution plan was implemented on June 8, 2022, with a cash dividend of RMB 0.30 per 10 shares (tax included)[180][181] - The company decided not to distribute cash dividends, issue bonus shares, or convert capital reserve into share capital for the 2022 fiscal year, retaining profits for future development[182] - The proportion of assets included in the evaluation scope accounts for 77.72% of the company's consolidated financial statement assets[186] - The proportion of revenue included in the evaluation scope accounts for 98.46% of the company's consolidated financial statement revenue[186] - No significant defects were found in the financial report and non-financial report[187] - The company has established quantitative standards for identifying defects, including thresholds for misstatements in assets, revenue, and profit[187] - The company has implemented control measures for financial reporting, including anti-fraud procedures and mechanisms for special transactions[187] Business Segments and Operations - The company's main business, technological advantages, and core competitiveness remain intact, with no significant risks to its ongoing operations[4] - The company developed a high-selectivity adsorption coupled with membrane concentration process for lithium extraction from salt lakes, enabling lithium extraction from brines with high Mg/Li ratios[30] - The company is collaborating with Qinghai Jintai Potash Fertilizer to further develop salt lake lithium resources using the company's proprietary technology[30] - The company's hazardous waste treatment business is expanding, with new investments in a Jilin acrylonitrile project currently under construction[31] - The company's industrial water treatment business is aligned with national policies promoting water conservation and efficiency, with a focus on industrial wastewater recycling[28] - The company's strategic focus has shifted to a diversified business model encompassing new materials, industrial water treatment, hazardous waste treatment, and new energy utilization[32] - The company's R&D investment in the petrochemical and chemical industry is expected to reach 1.5% of main business revenue by 2025, with a focus on high-end product development[32] - The hazardous waste treatment industry is expected to see a rebound in demand as economic recovery progresses, with a long-term trend towards resource utilization over simple disposal methods[34] - The industrial water treatment sector is poised for growth due to increasing urbanization and the shift towards low-carbon, green development models[33] - The company's water engineering and operation business includes EPC, EP, and PC models, providing comprehensive services for wastewater treatment and reuse in industries such as coal chemical, petrochemical, and fertilizer[36] - The company's subsidiary, Qinghai Wanbangda, is engaged in the investment, development, and production of salt lake resource products as part of its new energy comprehensive utilization business[37] - The company has developed a solid antioxidant automatic dosing technology, improving the antioxidant performance of C5 petroleum resin by approximately 20% compared to liquid antioxidants[39] - A new anti-acid corrosion washing system has been developed to enhance the mixing effect of catalysts in the washing system, upgrading the C5 petroleum resin production system[41] - The company has developed a complete set of high-concentration organic wastewater treatment technology, capable of treating wastewater with COD levels ranging from 2000 mg/L to hundreds of thousands of mg/L[42] - The company has optimized the lithium extraction process from salt lakes, achieving breakthroughs in low-cost battery-grade lithium salt production technology[43] - An electron beam irradiation technology pilot plant has been developed for treating industrial wastewater, particularly for difficult-to-degrade industrial wastewater[45] - The company has obtained 12 new patents, including 4 invention patents, covering areas such as high-concentration wastewater treatment, waste ion liquid recovery, high-salt water zero discharge, and lithium extraction from salt lake brine[38] - The company has established a comprehensive R&D system from small-scale testing to pilot-scale testing and engineering application promotion in the field of industrial wastewater treatment[46] - The company has developed multiple combined process routes for industrial wastewater treatment, including high-salt water zero discharge/salt fractionation, coking/lanxing wastewater treatment, and high-concentration organic wastewater treatment[46] - The company raised 342 million yuan through a private placement of A-shares, which will be used for the green circular economy resource utilization project in Jilin Chemical Industrial Park[54] - The company's new energy sector focuses on lithium extraction from salt lakes, with a 3000t/a lithium carbonate production line project under construction, involving an investment of 205.5 million yuan[59] - The company disposed of its subsidiary, American Yisike, for a total of 14 million yuan, resulting in a loss of control[63] - Established Guangdong Yisike with a registered capital of 100 million yuan, with the company contributing 60% of the capital[63] - Established Jiangxi Yinbai with a registered capital of 30 million yuan, with the company contributing 95% of the capital[65] - The top five customers accounted for 24.72% of total annual sales, with the largest customer contributing 11.52%[68] - The top five suppliers accounted for 85.59% of total annual procurement, with the largest supplier, CNOOC Shell Petrochemical Co., Ltd., contributing 64.39%[68] - R&D expenses increased by 38.05% year-on-year, mainly due to increased R&D investment and labor costs[70] - Financial expenses increased by 32.24% year-on-year, primarily due to increased discounting fees[70] - Developed a high-efficiency stirring and forced circulation system for the carbon five petroleum resin washing unit to enhance mixing effects, particularly in the first (immersion tank) and second (alkali washing) stages, achieving system upgrades[72] - Created an automatic intelligent dosing system for molten resin tanks to achieve precise and automatic addition of solid antioxidants, improving the anti-aging performance of carbon five petroleum resin and extending its storage period[72] - Optimized and combined different technologies for high-concentration organic wastewater treatment, including pretreatment and separation processes, to effectively treat typical high-concentration organic wastewater[72] - Completed adsorption experiments for different brines, determined lithium extraction adsorbents and process parameters, and developed a comprehensive utilization scheme for salt lake lithium resources[72] - Designed and compared different schemes for high-efficiency integrated biological reactors, completing the process drawing design for pilot-scale biological reactor equipment[72] - R&D personnel increased by 8.51% to 102 in 2022, with a slight increase in the proportion of R&D personnel to 7.90%[73] - R&D investment in 2022 was RMB 99,485,415.34, accounting for 3.66% of operating revenue, an increase from 3.59% in 2021[74] - Operating cash flow increased by 192.35% to RMB 877,876,368.74 in 2022, driven by increased sales and prices of petrochemical products[74] - Investment cash flow decreased by 61.69% to RMB 1,653,695,560.32 in 2022, mainly due to reduced recovery of financial products and PPP project funds[74] - Financing cash flow increased by 218.18% to RMB 105,000,000.00 in 2022, with a significant reduction in financing cash outflow by 40.34%[74] - The company developed a new industrial wastewater treatment process using electron beam irradiation technology, achieving stable operation and low cost[73] - The company conducted research on lithium extraction and lithium refining wastewater, aiming to improve lithium resource utilization and develop treatment solutions[73] - The company's R&D team includes 102 personnel, with 21.62% holding bachelor's degrees and 27.03% aged between 30-40 years[73] - The company plans to focus on new material business as its core, with coordinated development in new energy, water operations, and hazardous waste treatment sectors[86] - The company aims to enhance profitability in water operations by exploring new project development and cooperation opportunities, and improving operational teams and production management systems[87] - The company will accelerate the construction progress of the Guangdong project to ensure timely completion and operation[87] - The company plans to implement a quality and efficiency improvement initiative, focusing on market development, technical capabilities, and cost control[89] - The company will continue to prioritize technological innovation, establishing engineering technology centers and joint laboratories to drive key technology breakthroughs[90] - The company will strengthen internal control systems, optimize decision-making processes, and enhance team culture and talent development[90] - The company's subsidiary, Guangdong Yisike, plans to invest approximately RMB 7.33 billion in a high-end new materials project using carbon four and carbon five[179] - The project has 3 pressure tank areas using low-pressure spherical tanks, which effectively reduce static and working breathing losses, with a 97% reduction in non-methane total hydrocarbons and styrene emissions[135] - The flare system handles a small amount of exhaust gas at 700m³/h, with a NOX emission concentration below 100mg/m³ and an annual NOX emission of 0.56t/a[136] - Production wastewater system 1 handles 50t/h of wastewater, while system 2 processes 69.7t/h, with a total wastewater treatment capacity of 80t/h[137] - The company has established an emergency response plan for environmental incidents, including training, drills, and revisions, and completed an environmental safety assessment report[138] - The company adheres to the National Pollutant Discharge Permit requirements, ensuring compliance with air and water pollutant discharge standards[139] - The company focuses on reducing pollution and carbon emissions, integrating water and solid waste treatment businesses, and strengthening the new materials sector[140] - The company emphasizes shareholder rights protection, ensuring transparency and participation in major decisions, and safeguarding the interests of minority shareholders[142] - The company prioritizes employee rights, focusing on talent development, fair compensation, and career growth, while ensuring compliance with labor laws[142] - The company is committed to environmental protection, promoting energy-saving and emission-reduction projects, and advancing hazardous waste treatment technologies[143] - The company played a significant role in COVID-19 pandemic response by managing medical waste disposal and ensuring pollution control facilities operated effectively[145] - The company's subsidiary, Huizhou Yisike, has implemented comprehensive safety measures, including a three-level safety standardization system, regular safety inspections, and over 72 hours of safety training for new employees in 2022[146] - The company donated a total of 2 million RMB to establish the "Wanbangda Special Scholarship and Teaching Fund" at South China University of Technology and Beijing University of Chemical Technology to support talent development and academic-industry collaboration[146] - During the COVID-19 pandemic, the company donated 80,000 RMB to support epidemic prevention efforts in Jilin City, where its acrylonitrile project is located[147] - The company has not engaged in any activities related to poverty alleviation or rural revitalization during the reporting period[148] - The company's actual controllers and shareholders have made commitments to avoid unnecessary related-party transactions and ensure fair market practices, which have been fulfilled as of the reporting period[151] - The company established Guangdong Yisike with a registered capital of RMB 100 million, with the company contributing 60% (RMB 60 million) and Qinghai Hongdu New Materials Technology Co., Ltd. contributing 40% (RMB 40 million)[158] - The company established Jiangxi Yinbai with a registered capital of RMB 30 million, with the company contributing 95% (RMB 28.5 million) and Jiujiang Jishuntang Rehabilitation Health Management Co., Ltd. contributing 5% (RMB 1.5 million)[158] - As of December 31, 2022, Guangdong Yisike's paid-in capital was RMB 3 million, with the company

关于举行 2022 年度网上业绩说明会的公告 证券代码：300055 证券简称：万邦达 公告编号：2023-025 北京万邦达环保技术股份有限公司 关于举行 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 北京万邦达环保技术股份有限公司（以下简称"公司"）于 2023 年 4 月 20 日在巨潮资讯网上披露了《2022 年年度报告》及《2022 年年度报告摘要》。为了 让广大投资者能进一步了解公司经营业绩、发展战略等情况，公司定于 2023 年 5 月 8 日（星期一）15：00－17：00 在"价值在线"（www.ir-online.cn）举办 2022 年度网上业绩说明会，与投资者进行沟通和交流，广泛听取投资者的意见和建议。 一、业绩说明会召开的时间、地点和方式 1、会议召开时间：2023年5月8日（星期一）15:00-17:00 二、参加人员 出席本次年度业绩说明会的人员有：公司董事长兼总经理王飘扬先生、董事 兼副总经理兼财务总监宁长宇先生、独立董事李琪女士、董事兼副总经理兼董事 会秘书邓若男女士、东吴证券保荐代表人王永旭先 ...

Group 1: Investor Relations Activities - The investor relations activity was conducted on September 5, 2014, at 10 AM in the conference room of Beijing Shida Building [3] - Participants included representatives from various financial institutions such as Tianjin TEDA Fund and China International Capital Corporation [2] Group 2: Industry Insights - The coal chemical industry has shown stable operations, with no significant downturns reported [3] - The company is involved in a project related to circulating water and desalination, with a bid amount of 30 million [3] - Expected revenue from the Jilin solid waste project is 50 million, focusing on hazardous waste treatment, with Jilin Petrochemical accounting for approximately 70% of the waste in Jilin Province [4] Group 3: Financial Performance and Projections - The company anticipates confirming revenue from several projects, including a zero-discharge project and two smaller orders totaling approximately 120 million [5] - The company has signed contracts for new projects, expected to concentrate in the fourth quarter [5] Group 4: Mergers and Acquisitions - The company is focusing on mergers and acquisitions primarily in the industrial water sector, with no current plans to enter the medical water sector [5][6] - There is potential for acquiring municipal wastewater treatment companies, but financial indicators such as cash flow and accounts receivable are currently a concern [6]